Lacosamide Partial Onset Seizures
Links shared publicly online about this topic
Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures
medicalnewstoday.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seiz” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 4:07 pm By:
Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures http://mnt.to/3ybp #epilepsy
Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
physorg.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from the ...” View full resource at physorg.com
Most Recently Shared on February 25, 2010 at 7:11 pm By:
Lacosamide validated as promising therapy for uncontrolled partial-onset seizures http://tw.physorg.com/186329360
Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
sciencedaily.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures, and doses of 600mg/day may provide additional benefit for some patients.” View full resource at sciencedaily.com
Most Recently Shared on March 9, 2010 at 9:07 pm By:
Lacosamide validated as promising therapy for uncontrolled partial-onset seizures A recent multi-center study has con.. http://bit.ly/8X1cZx
Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years
medicalnewstoday.com — “The 29th International Epilepsy Congress in Rome, Italy (28th August-1st September) 1-4 presented consistent evidence this week, that a combined treatment with Vimpat® (lacosamide) has general” View full resource at medicalnewstoday.com
Most Recently Shared on September 2, 2011 at 7:04 am By:
Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years: The 29th ... http://t.co/Mec2KWC
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures - Drugs.com MedNews
drugs.com — “Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress New non-interventional study (VITOBA ) aims” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 10:01 pm By:
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with p... http://t.co/oazh0jZ #drug
UCB Media Centre - Vimpat® (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures
ucb.presscentre.com — “For the attention of accredited medical writers only• Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress • New non-interventional study (VITOBA™) aims to investigate additive or synergistic effects of lacosamide with single antiepileptic drug (AED) treatment” View full resource at ucb.presscentre.com
Most Recently Shared on August 31, 2011 at 12:24 pm By:
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs
medicalnewstoday.com — “Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patients” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomi... http://mnt.to/3PXs
AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy
news-medical.net — “UCB today announced that the antiepileptic drug (AED) Vimpat- (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.” View full resource at news-medical.net
Most Recently Shared on March 12, 2010 at 1:41 pm By:
Parkinson's Disease: AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy: UCB today anno... http://bit.ly/cjmdNU
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of Concomitant Antiepileptic Drugs - Drugs.com MedNews
drugs.com — “Comprehensive lacosamide analyses published in CNS Drugs - Pooled phase II III clinical trial data demonstrated efficacy and tolerability of lacosamide as adjun” View full resource at drugs.com
Most Recently Shared on January 12, 2011 at 7:18 pm By:
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of ... http://bit.ly/dQh82u #drug
Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Frequency and Improved Health-related Quality of Life - Drugs.com MedNews
drugs.com — “Data presented at the 64th Annual Meeting of the American Epilepsy Society - First presentation of the effects of long-term Vimpat treatment on patients self-re” View full resource at drugs.com
Most Recently Shared on December 7, 2010 at 9:07 pm By:
Long-term Use of Antiepileptic Drug Vimpat (Lacosamide) C-V Effectively Reduced Partial-Onset Seizure Freq... http://bit.ly/gFrSKZ #drug
Vimpat provides long-term additional partial-onset seizure control when added to broad range of AEDs
news-medical.net — “New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and ” View full resource at news-medical.net
Most Recently Shared on June 30, 2010 at 12:59 pm By:
Epilepsy News: Vimpat provides long-term additional partial-onset seizure control when added to broad range of AED... http://bit.ly/bDYwk4
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures
medicalnewstoday.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial” View full resource at medicalnewstoday.com
Most Recently Shared on October 4, 2010 at 3:05 pm By:
Epilepsy: Adjunctive Rufinamide Reduces Refractory Partial-Onset Seizures http://mnt.to/3KJ7 #epilepsy
ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...
ingentaconnect.com — “ingentaconnect Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with ...” View full resource at ingentaconnect.com
Most Recently Shared on September 26, 2011 at 5:06 am By:
Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy: (Source: CNS Drugs) http://t.co/PB9Wp1QV
Adjunctive rufinamide reduces refractory partial-onset seizures
physorg.com — “Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published ...” View full resource at physorg.com
Most Recently Shared on October 1, 2010 at 9:51 am By:
Adjunctive rufinamide reduces refractory partial-onset seizures http://tw.physorg.com/205131053
Trobalt / Potiga – Treatment for Partial-Onset Seizure - Drug Development Technology
drugdevelopment-technology.com — “Trobalt (Ezogabine / Retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged more than 18 years old. It is being developed and manufactured jointly by Canada-based Valeant Pharmaceuticals and...” View full resource at drugdevelopment-technology.com
Most Recently Shared on September 28, 2011 at 5:26 pm By:
Trobalt / Potiga – Treatment for Partial-Onset Seizure: Trobalt (Ezogabine / Retigabine) is indicated for the ... http://t.co/9rqjiggX
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Epilepsy News
The latest epilepsy news published daily. Articles from research centers, universities and prestigious journals.
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
-
medical_tweets
Advertisement

